GeneDx Holdings WGS
NASDAQ WGS
$101.10 -3.85 (-3.67%)
At close: Sep 18, 2026 · 4:00 PM EDT

GeneDx Holdings (WGS) Minority Interest (2020 - 2021)

GeneDx Holdings' (WGS) quarterly Minority Interest came in at $294.7 million in Q1 2021, down 16.55% quarter-over-quarter from $353.2 million in Q4 2020.

Analysis

GeneDx Holdings (WGS) Minority Interest (2020 - 2021) Analysis & Trends

GeneDx Holdings (WGS) has reported Minority Interest for 2 consecutive years, with $294.7 million the latest figure, recorded in Q1 2021.

  • On a quarterly basis, Minority Interest changed N/A year-over-year to $294.7 million in Q1 2021; TTM through Mar 2021 was $294.7 million, a N/A change from a year earlier, with the FY2020 full-year figure at $353.2 million, changed N/A from the prior year.
  • Minority Interest was $294.7 million for Q1 2021 at GeneDx Holdings, down from $353.2 million in the prior quarter.
  • Over five years, Minority Interest peaked at $353.2 million in Q4 2020 and troughed at $294.7 million in Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn
10 GeneDx Holdings 3.01 Bn 2.88 Bn 78.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 294.75 Mn
Dec 31, 2020 353.22 Mn